Duomed Group
Financials
Estimates*
EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | 13.4m | 10.6m | 11.8m | 9.6m | 20.4m | 37.7m | 54.0m |
% growth | (10 %) | (21 %) | 11 % | (19 %) | 113 % | 85 % | 43 % |
EBITDA | 2.5m | 1.1m | 2.3m | 1.2m | 4.4m | - | - |
% EBITDA margin | 19 % | 10 % | 19 % | 12 % | 22 % | - | - |
Profit | 1.3m | <1m | 1.1m | <1m | 2.6m | - | - |
% profit margin | 9 % | 2 % | 10 % | 3 % | 13 % | - | - |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Debt | ||
* | N/A | Acquisition | |
Total Funding | - |
Recent News about Duomed Group
EditDuomed Group is a comprehensive solution provider specializing in innovative medical products and services. Operating primarily in the Benelux region, Duomed serves a wide range of clients within the healthcare sector, including hospitals, clinics, and medical professionals. The company focuses on delivering high-quality, breakthrough medical solutions that enhance the quality, continuity, and safety of healthcare processes. Duomed's business model revolves around selling, installing, integrating, and maintaining advanced medical technologies. Revenue is generated through the sale of these products and the provision of ongoing support and maintenance services. By leveraging local expert teams, Duomed ensures that its solutions are seamlessly integrated into high-tech, critical medical environments, thereby optimizing operational excellence.
Keywords: medical solutions, healthcare, Benelux, hospitals, clinics, innovation, quality, continuity, safety, operational excellence.